ロード中...
Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice
To prevent clotting in the extracorporeal circuit during continuous renal replacement therapy (CRRT) anticoagulation is required. Heparin is still the most commonly used anticoagulant. However, heparins increase the risk of bleeding, especially in critically ill patients. Evidence has accumulated th...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672558/ https://ncbi.nlm.nih.gov/pubmed/23216871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc11645 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|